(3R,4R,5S)-4-acetamido-5-amino-3-isopropoxycyclohex-1-enecarboxylic acid

ID: ALA3220446

Chembl Id: CHEMBL3220446

PubChem CID: 90667104

Max Phase: Preclinical

Molecular Formula: C12H20N2O4

Molecular Weight: 256.30

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)N[C@@H]1[C@@H](N)CC(C(=O)O)=C[C@H]1OC(C)C

Standard InChI:  InChI=1S/C12H20N2O4/c1-6(2)18-10-5-8(12(16)17)4-9(13)11(10)14-7(3)15/h5-6,9-11H,4,13H2,1-3H3,(H,14,15)(H,16,17)/t9-,10+,11+/m0/s1

Standard InChI Key:  ANOPVQJRFFHSAA-HBNTYKKESA-N

Associated Targets(non-human)

NA Neuraminidase (2284 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
nanH Sialidase (337 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 256.30Molecular Weight (Monoisotopic): 256.1423AlogP: 0.03#Rotatable Bonds: 4
Polar Surface Area: 101.65Molecular Species: ZWITTERIONHBA: 4HBD: 3
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 4.08CX Basic pKa: 9.33CX LogP: -2.88CX LogD: -2.89
Aromatic Rings: Heavy Atoms: 18QED Weighted: 0.66Np Likeness Score: 1.31

References

1. Murumkar PR, Le L, Truong TN, Yadav MR.  (2011)  Determination of structural requirements of influenza neuraminidase type A inhibitors and binding interaction analysis with the active site of A/H1N1 by 3D-QSAR CoMFA and CoMSIA modeling,  (8): [10.1039/C1MD00050K]
2. Wang Z, Cheng LP, Zhang XH, Pang W, Li L, Zhao JL..  (2017)  Design, synthesis and biological evaluation of novel oseltamivir derivatives as potent neuraminidase inhibitors.,  27  (24): [PMID:29141777] [10.1016/j.bmcl.2017.11.003]

Source